Ccm Investment Advisers LLC Eli Lilly & CO Transaction History

Ccm Investment Advisers LLC

$887 Million
Q3 2024

A detailed history of Ccm Investment Advisers LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Ccm Investment Advisers LLC holds 14,914 shares of LLY stock, worth $12.1 Million. This represents 1.49% of its overall portfolio holdings.

Number of Shares

14,914

Previous 14,742 1.17%

Holding current value

$12.1 Million

Previous $13.3 Million 1.01%

% of portfolio

1.49%

Previous 1.57%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	BUY	$772.14 - $960.02 $132,808 - $165,123	172 Added 1.17%	14,914 $13.2 Million
Q2 2024 Jul 11, 2024	BUY	$724.87 - $909.04 $99,307 - $124,538	137 Added 0.94%	14,742 $13.3 Million
Q1 2024 May 17, 2024	BUY	$592.2 - $792.28 $8.01 Million - $10.7 Million	13,534 Added 1263.68%	14,605 $11.4 Million
Q4 2023 Mar 05, 2024	BUY	$525.19 - $619.13 $28,885 - $34,052	55 Added 5.41%	1,071 $624,000
Q2 2023 Aug 21, 2023	SELL	$350.74 - $468.98 $70,148 - $93,796	-200 Reduced 16.45%	1,016 $476,000
Q1 2023 May 17, 2023	SELL	$310.63 - $364.82 $4,659 - $5,472	-15 Reduced 1.22%	1,216 $417,000
Q4 2022 Feb 15, 2023	SELL	$321.55 - $374.67 $60,772 - $70,812	-189 Reduced 13.31%	1,231 $450,000
Q3 2022 Nov 09, 2022	SELL	$296.48 - $337.87 $16,306 - $18,582	-55 Reduced 3.73%	1,420 $459,000
Q1 2022 May 03, 2022	SELL	$234.69 - $291.66 $476,420 - $592,069	-2,030 Reduced 57.92%	1,475 $422,000
Q4 2021 Feb 01, 2022	SELL	$224.85 - $279.04 $449,700 - $558,080	-2,000 Reduced 36.33%	3,505 $968,000
Q2 2021 Jul 30, 2021	SELL	$180.55 - $233.54 $722,200 - $934,160	-4,000 Reduced 42.08%	5,505 $1.26 Million
Q4 2020 Feb 25, 2021	SELL	$130.46 - $172.63 $130 - $172	-1 Reduced 0.01%	9,505 $1.6 Million
Q3 2020 Nov 10, 2020	SELL	$146.22 - $169.13 $21,055 - $24,354	-144 Reduced 1.49%	9,506 $1.41 Million
Q2 2020 Aug 10, 2020	SELL	$136.42 - $164.18 $23,873 - $28,731	-175 Reduced 1.78%	9,650 $1.58 Million
Q1 2020 May 22, 2020	SELL	$119.05 - $147.35 $406,555 - $503,200	-3,415 Reduced 25.79%	9,825 $1.36 Million
Q4 2019 Feb 20, 2020	SELL	$106.92 - $132.43 $13,365 - $16,553	-125 Reduced 0.94%	13,240 $1.74 Million
Q3 2019 Nov 19, 2019	SELL	$106.79 - $116.16 $9.67 Million - $10.5 Million	-90,582 Reduced 87.14%	13,365 $1.49 Million
Q2 2019 Aug 05, 2019	SELL	$110.79 - $129.32 $897,177 - $1.05 Million	-8,098 Reduced 7.23%	103,947 $11.5 Million
Q1 2019 May 02, 2019	SELL	$111.31 - $131.02 $632,018 - $743,931	-5,678 Reduced 4.82%	112,045 $14.5 Million
Q4 2018 Feb 12, 2019	BUY	$105.9 - $118.64 $1.09 Million - $1.22 Million	10,264 Added 9.55%	117,723 $13.6 Million
Q3 2018 Nov 05, 2018	BUY	$85.86 - $107.31 $3.37 Million - $4.22 Million	39,290 Added 57.64%	107,459 $11.5 Million
Q2 2018 Aug 13, 2018	BUY	$75.7 - $86.88 $5.16 Million - $5.92 Million	68,169 New	68,169 $5.82 Million

Others Institutions Holding LLY

# of Institutions

3,965

Shares Held

751M

Call Options Held

6.32M

Put Options Held

8.66M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $771B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ccm Investment Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ccm Investment Advisers LLC with notifications on news.

Account

Ccm Investment Advisers LLC Eli Lilly & CO Transaction History